Skip to main content
OpenTrials
Completed

NCT Number: NCT00799344

REVEAL Study: Vessel Healing After Angioplasty

To address early vessel healing and thrombus formation after deployment of three distinct groups of stents

Completed

Looking for future studies?

Notify Me

Key information

Age range

21 year–70 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Ferrarotto Hospital

Catania, Sicily, 95124, Italy

About this study

A prospective, randomized study providing new evidences on early vessel healing and thrombus development after stenting with different devices.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Lesion length ≤ 20 mm
  • Two significant short lesions

Exclusion criteria

  • Life expectancy < 1 year
  • Left ventricular ejection fraction (LVEF) <30%
  • Chronic kidney disease

Treatment and study plan

Catania Stent

Device

coronary stent implantation

Primary outcomes

  1. percentage of "healed stent struts" at 28-32 days

    Time frame: 30 days

Secondary outcomes

  1. Measurement of neointimal growth on stent struts

    Time frame: 30 days

Sponsors and collaborators

Lead sponsor

CeloNova BioSciences, Inc.

Industry

Registry information

Official study title

Rapid Evaluation of Vessel HEaling After AngiopLasty (REVEAL) Trial: Rationale, Objectives and Design

Acronym: REVEAL

Important dates

Study start
2008
Primary completion
2009
Study completion
2009
First posted
Nov 27, 2008
Registry last updated
Jan 16, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.